BIO-RAD LABORATORIES -CL B (BIO.B) Stock Income Statement
USA - New York Stock Exchange - NYSE:BIO.B - US0905721082 - Common Stock
310.7 USD
-3.7 (-1.18%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.56B | 2.57B | 2.67B | 2.80B | 2.92B | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | 1.22B | 1.19B | 1.24B | 1.23B | 1.26B | |||
| Gross Profit | 1.34B | 1.38B | 1.43B | 1.57B | 1.66B | |||
| Operating Expenses | 1.08B | 1.08B | 1.07B | 1.08B | 1.10B | |||
| Research and Development | 271.22M | 266.40M | 240.93M | 256.80M | 247.30M | |||
| Selling, General, and Administrative Expenses | 806.96M | 814.00M | 824.22M | 824.80M | 851.00M | |||
| Operating Income | 262.53M | 298.50M | 365.70M | 486.80M | 564.70M | |||
| Interest Income/Expense | -1.06B | -2.61B | -1.19B | -5.17B | 4.95B | |||
| Other Income/Expense | -640.00K | 1.60M | 4.84M | -2.40M | 700.00K | |||
| Non Recurring Items | -44.10M | -29.50M | -27.90M | -17.50M | -65.20M | |||
| Income Before Taxes | -842.62M | -2.34B | -850.10M | -4.70B | 5.45B | |||
| Income Tax | -166.72M | -498.30M | -212.78M | -1.08B | 1.19B | |||
| Net Income | -675.90M | -1.84B | -637.32M | -3.63B | 4.25B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -24.30 | -65.36 | -21.82 | -121.72 | 140.87 | |||
| Non GAAP EPS | 10.31 | 10.31 | 11.77 | 14.23 | 15.67 | |||
| Statistics | ||||||||
| Gross Profit Margin | 52.42% | 53.73% | 53.56% | 55.97% | 56.91% | |||
| Profit Margin | -26.43% | -71.86% | -23.86% | -129.45% | 145.57% | |||
| Operating Profit Margin | 10.27% | 11.63% | 13.69% | 17.37% | 19.32% | |||
All data in USD